1. Home
  2. BYFC vs SAVA Comparison

BYFC vs SAVA Comparison

Compare BYFC & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYFC
  • SAVA
  • Stock Information
  • Founded
  • BYFC 1946
  • SAVA 1998
  • Country
  • BYFC United States
  • SAVA United States
  • Employees
  • BYFC N/A
  • SAVA N/A
  • Industry
  • BYFC Savings Institutions
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYFC Finance
  • SAVA Health Care
  • Exchange
  • BYFC Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • BYFC 63.8M
  • SAVA 70.5M
  • IPO Year
  • BYFC 1996
  • SAVA N/A
  • Fundamental
  • Price
  • BYFC $6.55
  • SAVA $1.77
  • Analyst Decision
  • BYFC
  • SAVA Buy
  • Analyst Count
  • BYFC 0
  • SAVA 3
  • Target Price
  • BYFC N/A
  • SAVA $54.50
  • AVG Volume (30 Days)
  • BYFC 11.2K
  • SAVA 822.2K
  • Earning Date
  • BYFC 04-28-2025
  • SAVA 05-08-2025
  • Dividend Yield
  • BYFC N/A
  • SAVA N/A
  • EPS Growth
  • BYFC N/A
  • SAVA N/A
  • EPS
  • BYFC N/A
  • SAVA N/A
  • Revenue
  • BYFC $32,732,999.00
  • SAVA N/A
  • Revenue This Year
  • BYFC N/A
  • SAVA N/A
  • Revenue Next Year
  • BYFC N/A
  • SAVA N/A
  • P/E Ratio
  • BYFC N/A
  • SAVA N/A
  • Revenue Growth
  • BYFC N/A
  • SAVA N/A
  • 52 Week Low
  • BYFC $4.41
  • SAVA $1.15
  • 52 Week High
  • BYFC $9.46
  • SAVA $42.20
  • Technical
  • Relative Strength Index (RSI)
  • BYFC 48.41
  • SAVA 56.59
  • Support Level
  • BYFC $6.36
  • SAVA $1.45
  • Resistance Level
  • BYFC $7.10
  • SAVA $1.67
  • Average True Range (ATR)
  • BYFC 0.36
  • SAVA 0.11
  • MACD
  • BYFC 0.01
  • SAVA 0.05
  • Stochastic Oscillator
  • BYFC 42.19
  • SAVA 81.40

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: